An interventional pain management practice near Nashville, Tennessee, offering umbilical cord derived regenerative cell injections alongside conventional pain procedures.
Interventional Pain Center is an interventional pain management group in the Nashville area of Tennessee. Note that the directory holds two entries for this same business, this one and the separate icp-pain-center listing; both resolve to the website ipcpaincenter.com and should be read as one practice. The regenerative service is one part of a broader pain practice that also offers diagnostic and therapeutic spinal injections, spinal cord stimulation and prolotherapy.
The cell treatment described on the site is allogeneic, meaning it comes from a donor rather than from the patient. It is presented as Wharton's jelly regenerative therapy, using cells from the Wharton's jelly of umbilical cord tissue. The site says the tissue is obtained from live, healthy births after delivery, states explicitly that the cells are not from aborted foetuses, and says the tissue is tested and stored in line with United States Food and Drug Administration compliance requirements. Mesenchymal stem cells are named as the cell type used; haematopoietic stem cells are referred to only in explaining blood cell production, not as a treatment offered.
The site includes a disclaimer stating that regenerative therapies of this kind are considered experimental and that none are approved by the United States Food and Drug Administration, and it notes that insurance generally does not cover them. A prospective patient should read that alongside the marketing: the clinic is describing a privately paid, experimental treatment rather than established care.
Conditions named for the cell treatment are osteoarthritis and degenerative joint disease, knee pain including meniscal and cruciate ligament tears, shoulder pain and rotator cuff injuries, hip pain, and chronic lower back pain. The practice lists seven clinicians across its Nashville and Hendersonville offices, with Dr Brad Wilson named as the interventional pain specialist available for regenerative consultations.
The list below is drawn from the site's own regenerative therapy page.
The site states that it uses mesenchymal stem cells obtained from the Wharton's jelly of umbilical cord tissue donated after live, healthy births, tested and stored in line with United States Food and Drug Administration compliance requirements.
Seven clinicians are listed across the practice.
The practice runs two outpatient offices in the Nashville area of Tennessee: the main Nashville site inside Skyline Medical Center at 3443 Dickerson Pike, Suite 730, and a second office at 353 New Shackle Island Road, Suite 148C, Hendersonville. Care is delivered as outpatient injections and procedures. Because the cell product is donor derived and supplied from outside, the site does not describe an on-site cell processing laboratory, and it states no accreditation or language provision.
No prices are published. The site states that insurance coverage is generally not available for these regenerative therapies, so the cost falls to the patient; the figure is not given and must be obtained from the clinic.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.